Abstract
We evaluated the efficacy of a depot preparation of growth hormone (GH) in a 15% gelatin solution (GH-gel) in the treatment of 15 growth hormone-deficient children. The studies were designed to see if prolonging absorption of GH to achieve lower more physiological concentrations of GH in plasma would decrease the frequency of injection, reduce the amount of GH needed for effective therapeutic response, and improve the response to long-term treatment. We found that after a single dose of GH-gel the plasma concentrations of GH were lower than those achieved after the standard aqueous preparation. The preparation was efficacious in promoting growth and our 1st study of 6 patients suggested that GH-gel given twice a week had a growth response equal to that of the three-times a week aqueous schedule. However both schedules resulted in the frequently observed decreased growth rate during the second treatment year. Our 2nd study, attempting to ameliorate this waning effect by using the GH-gel preparation twice a week in a weight-adjusted dose during the entire second year did not resolve the problem. Thus, GH in depot gel results in more physiological plasma concentrations of GH and may be beneficial in reducing the quantity of hormone needed and the injection frequency but it does not offer a solution to the waning response to the long-term administration of GH.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boden G., Soeldner J. S. A sensitive double antibody radioimmunoassay for human growth hormone (HGH): levels of serum HGH following rapid tolbutamide infusion. Diabetologia. 1967 Oct;3(5):413–421. doi: 10.1007/BF01228076. [DOI] [PubMed] [Google Scholar]
- ESCAMILLA R. F., HUTCHINGS J. J., DEAMER W. C., LI C. H., FORSHAM P. H. Long-term effects of human growth hormone (Li) in a pituitary dwarf. J Clin Endocrinol Metab. 1961 Jun;21:721–726. doi: 10.1210/jcem-21-6-721. [DOI] [PubMed] [Google Scholar]
- Eastman C. J., Lazarus L. Growth hormone release during sleep in growth retarded children. Arch Dis Child. 1973 Jul;48(7):502–507. doi: 10.1136/adc.48.7.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferrandez A., Zachmann M., Prader A., Illig R. Isolated growth hormone deficiency in prepubertal children. Influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. Helv Paediatr Acta. 1970 Dec;25(6):566–576. [PubMed] [Google Scholar]
- Frasier S. D., Aceto T., Jr, Hayles A. B., Mikity V. G. Collaborative study of the effects of human growth hormone in growth hormone deficiency: IV. Treatment with low doses of human growth hormone based on body weight. J Clin Endocrinol Metab. 1977 Jan;44(1):22–31. doi: 10.1210/jcem-44-1-22. [DOI] [PubMed] [Google Scholar]
- Frasier S. D., Aceto T., Jr, Hayles A. B., Parker M. L., Meyer-Bahlburg H. F. Collaborative study of the effects of human growth hormone in growth hormone deficiency. II. Development and significance of antibodies to human growth hormone during the first year of therapy. J Clin Endocrinol Metab. 1974 Jan;38(1):14–18. doi: 10.1210/jcem-38-1-14. [DOI] [PubMed] [Google Scholar]
- Frasier S. D., Costin G., Ling S. M., Kaplan S. A. Plasma growth hormone concentration after a single intramuscular injection of human growth hormone. Pediatr Res. 1969 Nov;3(6):557–561. doi: 10.1203/00006450-196911000-00005. [DOI] [PubMed] [Google Scholar]
- Hall K., Olin P. Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone. Acta Endocrinol (Copenh) 1972 Mar;69(3):417–433. doi: 10.1530/acta.0.0690417. [DOI] [PubMed] [Google Scholar]
- Kirkland R. T., Kirkland J. L., Librik L., Clayton G. W. Results of intermittent human growth hormone (HGH) therapy in hypopituitary dwarfism. J Clin Endocrinol Metab. 1973 Aug;37(2):204–211. doi: 10.1210/jcem-37-2-204. [DOI] [PubMed] [Google Scholar]
- Lippe B. M., Van Herle A. J., LaFranchi S. H., Uller R. P., Lavin N., Kaplan S. A. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J Clin Endocrinol Metab. 1975 Apr;40(4):612–618. doi: 10.1210/jcem-40-4-612. [DOI] [PubMed] [Google Scholar]
- Lippe B., Wong S. L., Kaplan S. A. Simultaneous assessment of growth hormone and ACTH reserve in children pretreated with diethylstilbestrol. J Clin Endocrinol Metab. 1971 Dec;33(6):949–956. doi: 10.1210/jcem-33-6-949. [DOI] [PubMed] [Google Scholar]
- Preece M. A., Tanner J. M., Whitehouse R. H., Cameron N. Dose dependence of growth response to human growth hormone in growth hormone deficiency. J Clin Endocrinol Metab. 1976 Mar;42(3):477–483. doi: 10.1210/jcem-42-3-477. [DOI] [PubMed] [Google Scholar]
- RABEN M. S. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab. 1958 Aug;18(8):901–903. doi: 10.1210/jcem-18-8-901. [DOI] [PubMed] [Google Scholar]
- Soyka L. F., Bode H. H., Crawford J. D., Flynn F. J., Jr Effectiveness of long-term human growth hormone therapy for short stature in children with growth hormone deficiency. J Clin Endocrinol Metab. 1970 Jan;30(1):1–14. doi: 10.1210/jcem-30-1-1. [DOI] [PubMed] [Google Scholar]
- Tanner J. M., Whitehouse R. H., Hughes P. C., Vince F. P. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child. 1971 Dec;46(250):745–782. doi: 10.1136/adc.46.250.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Underwood L. E., Azumi K., Voina S. J., Van Wyk J. J. Growth hormone levels during sleep in normal and growth hormone deficient children. Pediatrics. 1971 Dec;48(6):946–954. [PubMed] [Google Scholar]